Supplementary Methods Descriptions:
Plasmids and yeast strains:
All plasmids are listed Table S1 , and are derived from the original pVL438 plasmid that contains a genomic fragment and was provided by the Lundblad Lab (1). The XbaI and KpnI fragment (5327 nucleotides) encoding the Cdc13 protein was recloned in a pRS316 plasmid. The Cdc13 coding sequence was then tagged with 13 repeats of Myc coding sequence (2) , amplified by the p45 and p46 primers on DNA extracted from a Cdc13-Myc tagged genomic copy in strain MVY11. The PCR product was digested with both SacII and KpnI and cloned into the pVL438 vector prepared with the same digestion. The resulting plasmid pMS120-2 was sequenced and subjected to functional complementation analysis tests. All mutations described in this study were obtained by PCR mutagenesis with appropriate primers that are furnished upon request. All strains used in this study are listed in the Table S2 .
Southern blot and In-Gel Hybridization Analysis
For Southern blots, cells were grown to saturation in appropriate 5mL liquid cultures and DNA was extracted. For native in-gel analysis, strains were cultured in 50mL at the indicated temperature with the indicated carbon source until mid-log phase, cultures were split in two, one was maintained in the same condition as a control and the second half was treated as indicated in each experiment (carbon source, temperature and time of incubation). Total yeast genomic DNA was isolated using a modified glass bead procedure (3) . Southern blot and ingel hybridizations were done using, respectively 750ng and 1.5µg of XhoI digested DNA. For Southern analysis, DNA was denatured before being transferred to a nylon membrane and then hybridized using a telomeric probe. In-gel non-denaturing hybridization was done using a CA oligonucleotide probe as described (4) . To control for DNA loading, gels were denatured and re-probed with the CA oligonucleotide or transferred to a nylon membrane as in a Southern blot and probed with a telomeric probe. For in-gel quantification, the total signal for each lane in non-denaturing conditions was first normalized to the signal obtained with denatured DNA for the same lane; the obtained ratio was then compared to the control strains.
SDS PAGE and Western blot analysis:
Protein extracts were prepared using a modified trichloroacetic acid method. Proteins were separated by 6% SDS-PAGE for Cdc13-Myc blots and 10% for Rad53 blots, as described in (5) . Western blotting was performed using a mouse monoclonal anti-Myc antibody (Roche 11667149001, 1:500 dilution), a commercial Rabbit polyclonal anti-Rad53p antibody (Abcam, N° ab 104232, 1:500 dilution), a commercial mouse anti-PolII antibody (Covance #MMS-126R-200, 1:500 dilution), or a commercial Rat anti-HA antibody (Roche 11867423001, 1:500 dilution). Signals were revealed using horseradish peroxidase-conjugated anti-rabbit, antimouse or anti-rat antibodies with the enhanced chemiluminescence (ECL) detection kit (GEHealthcare).
Chromatin Immuno-Precipitation (ChIP) Analysis:
ChIP was performed with a modified protocol as derived from (6, 7) . Indicated strains were grown on appropriate media until reaching 10 7 cells/mL. Cells were cross-linked with 1% formaldehyde for 5 min on agitation. The cross-linking reaction was then stopped by 125mM of glycine for another 5 min. Harvested cells were washed with ice-cold HSB solution and resuspended in ChIP-Lysis buffer containing PMSF at a concentration equivalent to 2x10 8 cells/mL. Cells were immediately frozen by dropping them into liquid nitrogen to form popcorn.
Cell lysis was done in liquid nitrogen using a freezer mill method (1x2' pre-cooling, 4 cycles of: 2' of 15 pulses/sec + 2' cooling). After melting, 750µL of multiple aliquots, supplemented with 105µL of protease inhibitor cocktail, were subjected to sonication aiming for fragments of 0.2 to 1kb using a Misonix sonicator (10 cycles at 80%; 20'' ON and 40''OFF). For 1ml soluble extract, 2µg of mouse monoclonal anti-Myc antibody (Roche 11667149001, 1:500 dilution) was used and incubated for 2h at 4°C. Input samples were taken at this step. 25µL of equilibrated magnetic beads (Pierce TM Protein A/G Magnetic Beads #88802) were added for 2h for Chromatin immuno-precipitation. ChIP-beads were subject to different 5min wash steps with: SDS-Buffer, Hi-Salt-Buffer, T/L-Buffer, and T/E-Buffer (see below for composition).
Immunuprecipitates (IPs) were than eluted with 200µL as indicated in the manufacturer's protocol. After overnight crosslink reversal at 65°C, samples were subjected to RNase (100mg/mL) and Proteinase K (20mg/mL) treatment respectively for 1 and 6 hours incubation, followed by a phenol/chloroform and chloroform extraction. The DNA was then purified by Qiagen PCR kit purification. Immunoprecipitated and Input DNA were analyzed with qPCR quantification using Y' and CLN2 primers (sequences furnished upon request), and analyzed by the ΔΔCt method. Complete to 500 ml
Solutions for Chromatin IP and FreezerMill

Buffer
Immunofluorescence and microscopy
Immunofluorescence experiments were prepared as previously described (8) .
Exponentially growing cells (OD=0.5) were fixed with 5% formaldehyde in Buffer A (see below Localization and co-localization were manually counted and reported. Autoclave and cool it.
Solutions for Immunofluorescence on fixed Saccharomyces cerevisiae cells
2. 500 ml PPB 7.5 by mixing 1 M K2HPO4 (A) with 1 M KH2PO4 (B) until reaching pH 7.5.
Autoclave and store at 4°C.
 1 M potassium phosphate buffer at pH 6.5 (PPB6.5) :
Prepare 500 ml of 1 M potassium phosphate monobasic and 500 ml of 1 M potassium phosphate dibasic. Mix both buffers until the pH 6.5 is reached.
Make 500 ml of that. Autoclave and store at room temp.
 PPBMG pH 6.5 : 500 ml 1 M PPB at pH 6.5 60 ml for a final concentration of 120 mM MgCl2 0.06 g DdH2O 440 ml Autoclave and store at room temp.
 PBS 1X 1000 ml NaCl 8 g KCl 0.2 g Na2HPO4 1.14 g KH2PO4 0.2 g Adjust pH with 10N NaOH up to pH 7.3.
Co-immunoprecipitation assay (CoIP):
Immunoprecipitations were prepared as previously described (8), with slight modifications. Spplementary Tables:   Table S1 : Plasmids used in this study
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